Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2020 / Articles / Jan / Combating Coronavirus
Discovery & Development Vaccines Drug Discovery COVID-19 Research News

Combating Coronavirus

As the new virus spreads, more information is needed to mount an appropriate response.

By Stephanie Vine 01/30/2020 1 min read Quick Read (pre 2022)

Share

Elsevier has created a free information center on coronavirus 2019-nCoV that compiles clinical research, including content from medical journals, textbooks, clinical experts, major health organizations and more (1). The information is available in both English and Mandarin.

At the moment, no specific antiviral agent is available for treating the virus and there is no vaccine. However, researchers have already posted a sequence of 2019-CoV in a public database and some companies and institutes are already looking for a vaccine, including Massachusetts biotech Moderna, which is working with the US’s National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the Vaccine Research Center (2).

As of January 29, WHO reported that 6065 confirmed 2019-nCoV cases have been reported globally – the majority in China – including 132 deaths (3).

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Elsevier, “Novel Coronavirus Information Center,” (2020). Available at https://bit.ly/2RVgbQ3.
  2. CNBC, “Biotech firm Moderna is working on a vaccine for China’s deadly coronavirus,” (2020). Available at https://cnb.cx/2RvFyce.
  3. WHO, “Novel Coronavirus(2019-nCoV) Situation Report – 9,” (2020). Available at https://bit.ly/2REyo5H.

About the Author(s)

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

More Articles by Stephanie Vine

False

Advertisement

Recommended

False

Related Content

Understanding the H5N1 Threat
Vaccines Drug Discovery
Understanding the H5N1 Threat

February 3, 2025

4 min read

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

Peter Marks Resigns from FDA
Standards & Regulation Profession Vaccines Advanced Medicine
Peter Marks Resigns from FDA

April 1, 2025

3 min read

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr. “Rather he wishes subservient confirmation of his misinformation and lies.”

The Shingles Vaccine and Dementia
Drug Discovery Translational Science Vaccines
The Shingles Vaccine and Dementia

April 10, 2025

2 min read

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further

Robert F. Kennedy Jr Nomination Advances
Standards & Regulation Vaccines
Robert F. Kennedy Jr Nomination Advances

February 6, 2025

2 min read

Senate committee votes in favor of the nomination; full Senate vote will be next

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.